Peter Llewellyn-Davies

Peter Llewellyn-Davies is the founder of InvIOs GmbH, where he currently holds the title of Chief Executive Officer & Chief Financial Officer since 2022.
He is also the founder of Acceleration Partners LLC.
Additionally, Mr. Llewellyn-Davies currently holds the position of Chief Executive Officer at invIOs Holding AG since 2021, Chairman-Management Board at Biotechnologie-Industrie-Organisation Austria since 2020, Independent Non-Executive Director at Shield Therapeutics Plc since 2016, and Chief Executive & Financial Officer at APEIRON Biologics AG since 2018.
Previously, he held positions such as Executive Director-Finance at Süd-Chemie AG, Managing Director at Müller Dairy (UK) Ltd., Director at Catherex, Inc., Chief Financial Officer & Executive Director at Wilex, Inc., Non-Executive Director at Immunocore Holdings Plc, Member-Supervisory Board at 2invest AG from 2017 to 2021, Chief Financial Officer at CoreOptics GmbH, Chief Financial & Business Officer at MediGene AG from 2012 to 2016, and Chief Financial Officer at Heidelberg Pharma AG from 2010 to 2012.